Results of Operations and Financial Condition. On August 4, 2026, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 19…

Results of Operations and Financial Condition. On May 5, 2026, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934…

Other Events. The Company’s Second Amended and Restated Certificate of Incorporation and Second Amended and Restated By-laws provide that the size of the Board shall be determined from time to time by resolution of the Board. As a result of the events described in Item 5.02, the Board has taken action to reduce the size of the Board from eight to seven members, effective immediately upon Ms. Ross’s departure from the Board. In this regard, effective as of the conclusion of the 2026 Annual Mee…

Director — Bridget Ross: Ms. Ross notified the Board of her intent not to stand for re-election as a Class II director.

Results of Operations and Financial Condition. On February 25, 2026, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Ac…

Results of Operations and Financial Condition. On November 6, 2025, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Ac…

Results of Operations and Financial Condition. On August 5, 2025, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 19…

Results of Operations and Financial Condition. On May 1, 2025, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934…

Results of Operations and Financial Condition. On February 27, 2025, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Ac…

CFO — Dorian LeBlanc: The filing announces the appointment of an external candidate as CFO, which is a significant management change but not a departure of a sitting executive.

Creation of a Direct Financial Obligation or an Off-Balance Sheet Arrangement. The information set forth in

Unregistered Sales of Equity Securities. The information set forth under

Entry into a Material Definitive Agreement. Purchase Agreement On December 16, 2024 LeMaitre Vascular, Inc. (the “ Company ”) entered into a purchase agreement (the “ Purchase Agreement ”) with certain initial purchasers (the “ Initial Purchasers ”) agreeing, subject to customary conditions, to issue and sell $150 million principal amount of the Company’s 2.50% Convertible Senior Notes due 2030 (the “ Notes ”) to the Initial Purchasers. In addition, pursuant to the Purchase Agreement, the Com…

Regulation FD Disclosure. On December 16, 2024, LeMaitre Vascular, Inc. (the “Company”) issued a press release announcing that it had priced its offering of $150 million aggregate principal amount of 2.50% Convertible Senior Notes due 2030 (the “Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. A copy of the press release is furnished as Exhibit 99.1 and incorporated herein by reference. Neither this Current Rep…

Regulation FD Disclosure. On December 16, 2024, LeMaitre Vascular, Inc. (the “Company”) issued a press release announcing its intention to offer $150 million aggregate principal amount of Convertible Senior Notes due 2030 (the “Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. A copy of the press release is furnished as Exhibit 99.1 and incorporated herein by reference. Neither this Current Report on Form 8-K no…

Results of Operations and Financial Condition. On October 31, 2024, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Ac…

CFO — Joseph P. Pellegrino, Jr.: The CFO is retiring in an orderly manner with a defined timeline and will remain on the Board, indicating a planned succession rather than a sudden loss of executive leadership.

Results of Operations and Financial Condition. On August 1, 2024, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 19…

The provided text is only the standard Item 5.02 header and introductory fragment, containing no specific details about a person, role, or action to classify.

Results of Operations and Financial Condition. On May 2, 2024, LeMaitre Vascular, Inc. (the “Company”) issued a press release regarding its preliminary financial and operational results for the quarter ended March 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Report. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934…